DAVID A GOORAY
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease
- Where
- LARGO, MD
- NPI
- 1720070261
- Received
- $332,652 in 754 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 74 | $19,476 |
| 2024 | General payment | 59 | $15,170 |
| 2023 | General payment | 82 | $22,505 |
| 2022 | General payment | 64 | $30,979 |
| 2021 | General payment | 77 | $42,160 |
| 2020 | General payment | 89 | $51,097 |
| 2019 | General payment | 309 | $151,262 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 197 | $283,390 |
| Travel and Lodging | 60 | $25,788 |
| Food and Beverage | 487 | $14,499 |
| Consulting Fee | 4 | $8,715 |
| Education | 6 | $259 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | Mannkind Corporation | $22 | Food and Beverage | In-kind items and services | AFREZZA Drug, DIABETES MEDICINE | 2025 | |
| 2025-12-16 | scPharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-12-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | $688 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-12-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | $117 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-12-05 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-12-04 | E.R. Squibb & Sons, L.L.C. | $10 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-11-20 | BridgeBio Pharma, Inc. | $109 | Food and Beverage | In-kind items and services | Attruby Drug, Cardiomyopathy | 2025 | |
| 2025-11-20 | Bayer Healthcare Pharmaceuticals Inc. | $26 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-11-19 | Bayer Healthcare Pharmaceuticals Inc. | $1,884 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-11-17 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-11-13 | Bayer Healthcare Pharmaceuticals Inc. | $1,884 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-11-13 | Bayer Healthcare Pharmaceuticals Inc. | $70 | Travel and Lodging | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-11-08 | Bayer Healthcare Pharmaceuticals Inc. | $26 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-11-07 | Bayer Healthcare Pharmaceuticals Inc. | $56 | Travel and Lodging | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-31 | Bayer Healthcare Pharmaceuticals Inc. | $2,591 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-31 | Bayer Healthcare Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-29 | Bayer Healthcare Pharmaceuticals Inc. | $29 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-28 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-27 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2025 | |
| 2025-10-24 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-24 | scPharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-10-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-08 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | WAINUA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-10-06 | Bayer Healthcare Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-06 | Bayer Healthcare Pharmaceuticals Inc. | $2 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-02 | Bayer Healthcare Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-09-30 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2025 | |
| 2025-09-18 | Bayer Healthcare Pharmaceuticals Inc. | $1,884 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-09-12 | Bayer Healthcare Pharmaceuticals Inc. | $10 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-09-10 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-09-08 | scPharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-09-05 | Actelion Pharmaceuticals US, Inc. | $34 | Food and Beverage | In-kind items and services | OPSUMIT Drug, Cardiology | 2025 | |
| 2025-09-03 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-08-27 | Bayer Healthcare Pharmaceuticals Inc. | $118 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-17 | Bayer Healthcare Pharmaceuticals Inc. | $275 | Travel and Lodging | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-17 | Bayer Healthcare Pharmaceuticals Inc. | $161 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-17 | Bayer Healthcare Pharmaceuticals Inc. | $115 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-17 | Bayer Healthcare Pharmaceuticals Inc. | $65 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-16 | AstraZeneca Pharmaceuticals LP | $26 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-08-04 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-08-04 | E.R. Squibb & Sons, L.L.C. | $2 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-07-22 | Bayer Healthcare Pharmaceuticals Inc. | $520 | Travel and Lodging | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-07-09 | Bayer Healthcare Pharmaceuticals Inc. | $22 | Travel and Lodging | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-06-20 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-06-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-06-17 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-06-13 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-06-03 | scPharmaceuticals Inc. | $36 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-05-28 | Boehringer Ingelheim Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-05-27 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-05-17 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | VYNDAQEL Drug, CARDIOVASCULAR | 2025 | |
| 2025-05-15 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-05-15 | E.R. Squibb & Sons, L.L.C. | $6 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-05-15 | E.R. Squibb & Sons, L.L.C. | $1 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-05-14 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2025 | |
| 2025-05-13 | Actelion Pharmaceuticals US, Inc. | $22 | Food and Beverage | In-kind items and services | OPSUMIT Drug, Cardiology | 2025 | |
| 2025-05-05 | Bayer Healthcare Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-04-24 | E.R. Squibb & Sons, L.L.C. | $104 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-04-16 | Novo Nordisk Inc | $33 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-12 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | VYNDAQEL Drug, CARDIOVASCULAR | 2025 | |
| 2025-04-08 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-03-21 | E.R. Squibb & Sons, L.L.C. | $31 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-03-21 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2025 | |
| 2025-02-24 | Lilly USA, LLC | $1,560 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-02-08 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | VYNDAQEL Drug, CARDIOVASCULAR | 2025 | |
| 2025-02-07 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-01-31 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-01-31 | E.R. Squibb & Sons, L.L.C. | $8 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-01-31 | E.R. Squibb & Sons, L.L.C. | $0 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-01-15 | Merck Sharp & Dohme LLC | $27 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2025 | |
| 2025-01-09 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-01-02 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2024-12-19 | scPharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2024 | |
| 2024-11-15 | scPharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2024 | |
| 2024-11-06 | Merck Sharp & Dohme LLC | $24 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2024 | |
| 2024-11-04 | Bayer Healthcare Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-11-02 | Actelion Pharmaceuticals US, Inc. | $37 | Food and Beverage | In-kind items and services | OPSUMIT Drug, Cardiology | 2024 | |
| 2024-10-31 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-10-24 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-10-11 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-09-13 | Novo Nordisk Inc | $35 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-09-11 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2024 | |
| 2024-09-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-08-23 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-07-30 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-07-25 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-07-17 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-11 | Lexicon Pharmaceuticals, Inc. | $28 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-21 | HEARTFLOW, INC. | $20 | Food and Beverage | Cash or cash equivalent | FFRct Device, Coronary | 2024 | |
| 2024-06-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $2,080 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $770 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-06-13 | Merck Sharp & Dohme LLC | $25 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2024 | |
| 2024-06-05 | Lilly USA, LLC | $122 | Food and Beverage | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-06-05 | Bayer Healthcare Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-05-31 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-05-23 | Actelion Pharmaceuticals US, Inc. | $28 | Food and Beverage | In-kind items and services | OPSUMIT Drug, Cardiology | 2024 | |
| 2024-05-20 | Lexicon Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-05-14 | AstraZeneca Pharmaceuticals LP | $119 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-05-10 | E.R. Squibb & Sons, L.L.C. | $26 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-05-10 | E.R. Squibb & Sons, L.L.C. | $2 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-05-09 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-04-30 | AstraZeneca Pharmaceuticals LP | $11 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-23 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | STELARA Biological, Immunology | 2024 | |
| 2024-04-23 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-04-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-04-12 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-29 | GlaxoSmithKline, LLC. | $30 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2024 | |
| 2024-03-26 | Lexicon Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-22 | Bayer Healthcare Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-03-22 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VIBERZI Drug, GASTROENTEROLOGY | 2024 | |
| 2024-03-20 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | WAINUA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-03-06 | Corcept Therapeutics | $128 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-03-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $336 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-03-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $185 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-03-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $50 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-03-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $50 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-03-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $40 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-03-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $40 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-03-05 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2024 | |
| 2024-02-27 | Corcept Therapeutics | $19 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-02-15 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-02-13 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-01-31 | Lilly USA, LLC | $4,420 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-01-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $231 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-01-10 | Corcept Therapeutics | $21 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-01-02 | Boehringer Ingelheim Pharmaceuticals, Inc. | $533 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2023-12-12 | Lexicon Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | Inpefa Drug, Inhibitor of SGLT2 and SGLT1 | 2023 | |
| 2023-11-14 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2023 | |
| 2023-10-31 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-10-30 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-10-26 | Lilly USA, LLC | $260 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-10-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,825 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-10-18 | Bayer Healthcare Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-10-13 | Boehringer Ingelheim Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2023 | |
| 2023-10-03 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | LINZESS Drug, GASTROENTEROLOGY | 2023 | |
| 2023-09-26 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2023 | |
| 2023-09-20 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-09-13 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2023 | |
| 2023-09-12 | Corcept Therapeutics | $27 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2023 | |
| 2023-09-09 | GlaxoSmithKline, LLC. | $25 | Food and Beverage | In-kind items and services | TRELEGY ELLIPTA Drug, RESPIRATORY | 2023 | |
| 2023-09-05 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-08-30 | Lexicon Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | Inpefa Drug, Inhibitor of SGLT2 and SGLT1 | 2023 | |
| 2023-08-28 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2023 | |
| 2023-08-26 | Actelion Pharmaceuticals US, Inc. | $20 | Food and Beverage | In-kind items and services | OPSUMIT Drug, Cardiology | 2023 | |
| 2023-08-25 | Actelion Pharmaceuticals US, Inc. | $99 | Education | In-kind items and services | OPSUMIT Drug, Cardiology | 2023 | |
| 2023-08-25 | Azurity Pharmaceuticals, Inc. | $17 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-08-24 | Azurity Pharmaceuticals, Inc. | $2 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-08-23 | Boston Scientific Corporation | $77 | Food and Beverage | In-kind items and services | Device, CDS broad portfolio offering_CRM | 2023 | |
| 2023-08-23 | Bayer Healthcare Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-08-02 | Lilly USA, LLC | $1,310 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-08-02 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-08-01 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | VYNDAQEL Drug, CARDIOVASCULAR | 2023 | |
| 2023-07-26 | Boston Scientific Corporation | $54 | Food and Beverage | In-kind items and services | Device, CDS broad portfolio offering_CRM | 2023 | |
| 2023-07-26 | Lilly USA, LLC | $1 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-07-25 | Lilly USA, LLC | $6 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-07-25 | Lilly USA, LLC | $1 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-07-23 | Azurity Pharmaceuticals, Inc. | $7 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-07-22 | Azurity Pharmaceuticals, Inc. | $13 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-07-19 | Lexicon Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Inpefa Drug, Inhibitor of SGLT2 and SGLT1 | 2023 | |
| 2023-07-18 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-07-12 | Bayer Healthcare Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-06-28 | Lexicon Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Inpefa Drug, Inhibitor of SGLT2 and SGLT1 | 2023 | |
| 2023-06-23 | Azurity Pharmaceuticals, Inc. | $22 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-06-23 | Azurity Pharmaceuticals, Inc. | $2 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-06-22 | Amarin Pharma, Inc. | $13 | Food and Beverage | In-kind items and services | Vascepa Drug, Cardiovascular | 2023 | |
| 2023-06-21 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2023 | |
| 2023-06-14 | Lilly USA, LLC | $2,080 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-06-14 | Lilly USA, LLC | $1,045 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-06-12 | Bayer Healthcare Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-06-07 | Lilly USA, LLC | $105 | Food and Beverage | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-06-07 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-06-03 | Azurity Pharmaceuticals, Inc. | $23 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-06-02 | Azurity Pharmaceuticals, Inc. | $1 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-06-01 | Actelion Pharmaceuticals US, Inc. | $27 | Food and Beverage | In-kind items and services | UPTRAVI Drug, Cardiology | 2023 | |
| 2023-05-16 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-05-16 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2023 | |
| 2023-05-15 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-05-11 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-05-10 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-05-09 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2023 | |
| 2023-05-07 | Azurity Pharmaceuticals, Inc. | $4 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-05-06 | Azurity Pharmaceuticals, Inc. | $16 | Food and Beverage | Cash or cash equivalent | Edarbi Drug, Cardiology/Vascular Diseases | 2023 | |
| 2023-05-04 | E.R. Squibb & Sons, L.L.C. | $26 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2023 | |
| 2023-05-03 | Bayer Healthcare Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-05-03 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2023 | |
| 2023-05-02 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-05-02 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-04-27 | scPharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | FUROSCIX Drug, Cardiology | 2023 | |
| 2023-04-25 | Merck Sharp & Dohme LLC | $110 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2023 | |
| 2023-04-18 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2023 | |
| 2023-04-17 | Lilly USA, LLC | $1,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-04-14 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VIBERZI Drug, GASTROENTEROLOGY | 2023 | |
| 2023-04-14 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | ENTRESTO Drug, Cardiology/Vascular Diseases | 2023 |
The latest 200 records of 754.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Largo, MD, county Prince George's County, MD, state Maryland; placed by its city name.
| Measure | Place (city or town) Largo, MD | County Prince George's County, MD | State Maryland |
|---|---|---|---|
| Population B01003 | 12,229 | 959,754 | 6,206,011 |
| Population, 2020 census P1 | 11,605 | 967,201 | 6,177,224 |
| Median age B01002 | 39.6 | 38.5 | 39.4 |
| Under 18 B01001 | 18.9% | 22.1% | 22.2% |
| 65 and over B01001 | 14.8% | 14.9% | 16.7% |
| Households B11001 | 5,295 | 347,744 | 2,362,928 |
| Foreign born B05002 | 16.3% | 25.3% | 16.6% |
| Median household income B19013 | $103,375 | $101,798 | $103,678 |
| Median family income B19113 | $136,696 | $120,601 | $127,817 |
| Per capita income B19301 | $54,435 | $46,366 | $52,979 |
| Poverty rate B17001 | 7.2% | 10.8% | 9.4% |
| Unemployment rate B23025 | 6.7% | 6.4% | 4.9% |
| Civilian labor force B23025 | 7,480 | 531,986 | 3,313,651 |
| Mean commute (minutes) B08013 | 33.1 | 35.2 | 31.1 |
| Bachelor's degree or higher B15003 | 45.6% | 36.7% | 43.4% |
| Housing units B25001 | 5,534 | 365,506 | 2,560,784 |
| Owner-occupied B25003 | 63.2% | 62.3% | 67.6% |
| Renters B25003 | 36.8% | 37.7% | 32.4% |
| Median home value B25077 | $387,800 | $426,000 | $419,900 |
| Median gross rent B25064 | $2,180 | $1,799 | $1,705 |
| White, not Hispanic B03002 | 2.9% | 10.8% | 46.6% |
| Black B03002 | 86.5% | 58.2% | 28.9% |
| Hispanic or Latino B03002 | 1.7% | 22.5% | 12.5% |
| Asian B03002 | 1.6% | 3.9% | 6.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Largo, MD.
Comments